Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Infographic
A better approach to risk-based monitoring
There are many challenges facing clinical development today: study protocol complexity, costs, finding the right sites and patients, and data integration complexity are just a few. Risk-based monitoring (RBM) is becoming an industry standard in order to mitigate these risks and challenges. Partner with IQVIA, the RBM market leader, to reduce risks and costs, improve data quality, and enhance patient safety. Learn more about how you can execute your RBM trials with confidence by partnering with IQVIA in our latest RBM infographic.
Related solutions
Connected Devices
Clinical Trials
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Clinical Research & Development Solutions
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
